“A prospective study to monitor the side effects associated with disease modifying anti rheumatoid drugs in out-patients of tertiary care hospital”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 12, no. 1, pp. 1–7, Feb. 2023, doi: 10.61096/ijrpp.v12.iss1.2023.1-7.